BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, announced ...

September 26, 2023 | News

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...

September 26, 2023 | News

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...

September 26, 2023 | News

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...

September 25, 2023 | News

AstraZeneca and Institut Kanser Negara Collaborate to Introduce AI Lung Screening in Malaysia

In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisati...

September 25, 2023 | News

Inmagene Forms Celexor Bio with Enhanced anti-ILT7 mAb

"We are pleased to partner with Aditum Bio, a highly innovative venture capital firm established by pharma industry leaders with deep drug development expe...

September 22, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)

Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...

September 15, 2023 | News

deCODE Genetics and Collaborators Reveal Complex Impact of Sequence Variants on Lipid Levels and Heart Disease

Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and The Copenhagen University,...

September 15, 2023 | News

MGI and Bio-Medical Science Partner to Provide Advanced Sequencing Solutions to South Korea

"This MOU marks a key milestone for the development of genomics in South Korea as we introduce localized, high-quality and cost-effective solutio...

September 14, 2023 | News

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In additio...

September 13, 2023 | News

Roche Diagnostics and Burjeel Holdings Join Forces for Enhanced Digital Diagnostics and Patient Care

Roche Diagnostics Middle East FZCO, a global leader in diagnostics, and Burjeel Holdings, one of the largest healthcare services providers in the MENA regi...

September 11, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

Gloria Biosciences' Zimberelimab Approved in China for Recurrent Cervical Cancer

Guangzhou Gloria Biosciences ("GloriaBio"), a commercial stage biopharmaceutical company focusing on the discovery, development and commercialization of bi...

September 07, 2023 | News

Stay Connected